Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
EVOLUTION
Show more
Decellularized membrane, dermal and connective tissue products sourced from placentas and cadavers that serve as a cover or barrier and provide protection from the surrounding environment in medical, surgical and veterinary applications but not including medical, surgical and veterinary dressings, namely pads, ointments or bandages
Class 5 – Pharmaceuticals & supplements
Status timeline
- 2 Apr 2022Application filedNew Application Entered
- 14 Jan 2023Assigned to an examining attorneyAssigned To Examiner
- 20 Jan 2023Office action issuedNon-Final Action Written
- 20 Jul 2023Response to office action filedTeas Response To Office Action Received
- 10 Aug 2023Approved for publicationApproved For Pub - Principal Register
- 19 Sep 2023Published for oppositionPublished For Opposition
- 14 Nov 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 13 May 2024Statement of use filedTeas Statement Of Use Received
- 15 Jun 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 23 Jul 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 27 Aug 2024Registered on the Principal RegisterRegistered-Principal Register
All 27 events
| 2024-08-27 | Registered-Principal Register |
| 2024-08-27 | Notice Of Registration Confirmation Emailed |
| 2024-07-23 | Allowed Principal Register - Sou Accepted |
| 2024-07-23 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-06-15 | Case Assigned To Intent To Use Paralegal |
| 2024-06-15 | Sou Extension 1 Granted |
| 2024-06-15 | Statement Of Use Processing Complete |
| 2024-05-13 | Sou Teas Extension Received |
| 2024-05-13 | Teas Statement Of Use Received |
| 2024-05-13 | Sou Extension 1 Filed |
| 2024-05-13 | Use Amendment Filed |
| 2023-11-14 | Noa Mailed - Sou Required From Applicant |
| 2023-09-19 | Published For Opposition |
| 2023-09-19 | Official Gazette Publication Confirmation E-Mailed |
| 2023-08-30 | Notification Of Notice Of Publication E-Mailed |
| 2023-08-10 | Approved For Pub - Principal Register |
| 2023-07-21 | Teas/Email Correspondence Entered |
| 2023-07-20 | Teas Response To Office Action Received |
| 2023-07-20 | Correspondence Received In Law Office |
| 2023-04-20 | Application Extension To Response Period - Received |
| 2023-04-20 | Application Extension Granted/Receipt Provided |
| 2023-01-20 | Non-Final Action Written |
| 2023-01-20 | Non-Final Action E-Mailed |
| 2023-01-20 | Notification Of Non-Final Action E-Mailed |
| 2023-01-14 | Assigned To Examiner |
| 2022-04-05 | New Application Office Supplied Data Entered |
| 2022-04-02 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Decellularized membrane, dermal and connective tissue products sourced from placentas and cadavers that serve as a cover or barrier and provide protection from the surrounding environment in medical, surgical and veterinary applications but not including medical, surgical and veterinary dressings, namely pads, ointments or bandages
First use anywhere 1 Jul 2020 · First use in commerce 15 Mar 2024
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 27 Aug 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.